نتائج البحث

Neurosteroid Levels in GBA Mutated and Non-Mutated Parkinson's Disease: A Possible Factor Influencing Clinical Phenotype?

• Authors : Cavallieri F; Neurology Unit, Neuromotor & Rehabilitation Department, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy.; Lucchi C

Subjects: Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/genetics ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/blood ; Glucosylceramidase*/Glucosylceramidase*/Glucosylceramidase*/genetics

• Source: Biomolecules [Biomolecules] 2024 Aug 17; Vol. 14 (8). Date of Electronic Publication: 2024 Aug 17.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101596414 Publication Model: Electronic Cited Medium: Internet ISSN: 2218-273X

تفاصيل العنوان

Correction: Parkinson's disease in a patient with GBA and LRRK2 covariants after acute hypoxic insult: a case report.

• Authors : Tang Y; Department of Neurology, , Guangzhou, China, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.; Wei L

• Source: BMC neurology [BMC Neurol] 2024 Oct 18; Vol. 24 (1), pp. 400. Date of Electronic Publication: 2024 Oct 18.Publisher: BioMed Central Country of Publication: England NLM ID: 100968555 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2377

تفاصيل العنوان

GBA-associated Parkinson's disease in Hungary: clinical features and genetic insights.

• Authors : Szlepák T; Institute of Genomic Medicine and Rare Disorders, Semmelweis University, Budapest, Hungary.; HUN-REN, Multiomic Neurodegeneration Research Group, Budapest, Hungary.

Subjects: Glucosylceramidase*/Glucosylceramidase*/Glucosylceramidase*/genetics ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/genetics; Humans

• Source: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2024 Jun; Vol. 45 (6), pp. 2671-2679. Publisher: Springer-Verlag Italia Country of Publication: Italy NLM ID: 100959175 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Study protocol of the GRoningen early-PD Ambroxol treatment (GREAT) trial: a randomized, double-blind, placebo-controlled, single center trial with ambroxol in Parkinson patients with a GBA mutation.

• Authors : Siemeling O; Department of Neurology, University Medical Center Groningen, Groningen, The Netherlands. .; Parkinson Expertise Center Groningen, Groningen, The Netherlands. .

Subjects: Ambroxol*/Ambroxol*/Ambroxol*/administration & dosage ; Ambroxol*/Ambroxol*/Ambroxol*/therapeutic use ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/drug therapy

• Source: BMC neurology [BMC Neurol] 2024 May 01; Vol. 24 (1), pp. 146. Date of Electronic Publication: 2024 May 01.Publisher: BioMed Central Country of Publication: England NLM ID: 100968555 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2377

تفاصيل العنوان

Comparing the effects of GBA variants and onset age on clinical features and progression in Parkinson's disease.

• Authors : Ren J; Department of Neurology, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, China.; Zhan X

Subjects: Cognitive Dysfunction* ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/diagnosis ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/genetics

• Source: CNS neuroscience & therapeutics [CNS Neurosci Ther] 2024 Feb; Vol. 30 (2), pp. e14387. Date of Electronic Publication: 2023 Aug 10.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101473265 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Where neurostimulation meets neurodegeneration in Parkinson's disease related to GBA variants.

• Authors : Shih LC; Department of Neurology, Boston Medical Center, Boston, Massachusetts, USA.; Department of Neurology, Chobanian and Avedisian Boston University School of Medicine, Boston, Massachusetts, USA.

Subjects: Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/complications ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/therapy; Humans

• Source: Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2024 Apr; Vol. 11 (4), pp. 840-841. Date of Electronic Publication: 2024 Mar 26.Publisher: Wiley Periodicals, Inc on behalf of American Neurological Association Country of Publication: United States NLM ID: 101623278 Publication Model:

تفاصيل العنوان

Unraveling Autonomic Dysfunction in GBA-Related Parkinson's Disease.

• Authors : Devigili G; Fondazione IRCCS Istituto Neurologico Carlo Besta, Department of Clinical Neurosciences, Parkinson and Movement Disorders Unit, Milan, Italy.; Straccia G

• Source: Movement disorders clinical practice [Mov Disord Clin Pract] 2023 Oct 13; Vol. 10 (11), pp. 1620-1638. Date of Electronic Publication: 2023 Oct 13 (Print Publication: 2023).Publisher: Wiley Country of Publication: United States NLM ID: 101630279 Publication Model: eCollection Cited Medium: Internet ISSN: 2330-1619

تفاصيل العنوان

Quantitative dopamine transporter imaging assessment in Parkinson's disease patients carrying GBA gene mutations compared with idiopathic PD patients: A case-control study.

• Authors : Grisanti S; Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy.; Fraternali A

Subjects: Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/diagnostic imaging ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/genetics ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/metabolism

• Source: Brain and behavior [Brain Behav] 2023 Jul; Vol. 13 (7), pp. e3060. Date of Electronic Publication: 2023 Jun 01.Publisher: John Wiley & Sons Country of Publication: United States NLM ID: 101570837 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Parkinson's disease in a patient with GBA and LRRK2 covariants after acute hypoxic insult: a case report.

• Authors : Tang Y; Department of Neurology, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.; Wei L

Subjects: Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/complications ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/genetics; Male

• Source: BMC neurology [BMC Neurol] 2023 Jun 10; Vol. 23 (1), pp. 226. Date of Electronic Publication: 2023 Jun 10.Publisher: BioMed Central Country of Publication: England NLM ID: 100968555 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2377

تفاصيل العنوان

The Consequences of GBA Deficiency in the Autophagy-Lysosome System in Parkinson's Disease Associated with GBA.

• Authors : Pradas E; Neurodegenerative Diseases Research Group, Vall d'Hebron Research Institute-CIBERNED, 08035 Barcelona, Spain.; Protein Engineering and Nanomedicine Group, Institut de Biotecnologia i Biomedicina, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Spain.

Subjects: Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/metabolism ; Gaucher Disease*; Humans

• Source: Cells [Cells] 2023 Jan 03; Vol. 12 (1). Date of Electronic Publication: 2023 Jan 03.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409

تفاصيل العنوان